Relapse to drug use following periods of abstinence is a significant impediment in the long-term treatment of cocaine dependence. Environmental stimuli or contexts previously associated with drug use or priming doses of the abused drug can initiate relapse to compulsive drug-seeking and drug-taking behaviors. Project 4 will take intervention strategies identified through the NARC projects aimed at reducing relapse to cocaine-seeking and systematically test compounds that will hopefully show significant and selective attenuation of cocaine-seeking in the relapse model. The advantages of having such a project within the NARC include: a) the ability to use standardized procedures through the NARC Animal Core of cocaine selfadministration and reinstatement, b) testing acute and chronic drug treatment protocols that inhibit cocaineseeking that can be further used in other NARC projects to assess the validity of cocaine-induced neuroplasticity for drug target development, and c) integrating the NARC preclinical animal model of relapse with potential clinical projects in the NARC Pilot Core as a transition to clinical assessment of promising pharmacotherapies. Project 4 will initially focus on a few selected strategies of drug intervention by targeting dopaminergic activity via a partial DA receptor agonist, enhancement of glutamatergic homeostasis, and antagonism of the orexin receptor. The proposed experiments will assess the effects of drug intervention after varied periods of cocaine-taking history, during and after extinction training, following abstinence in the absence of extinction, and in response to both conditioned cues and cocaine priming injections. Additional experiments will determine the effects of test compounds on ongoing cocaine-taking and responding for non-drug reinforcement (i.e., food). Since the focus of Project 4 will be the assessment of compounds that can be quickly applied in a clinical environment, we will initially focus on systemically available, approved drugs for use in humans. However, in years 4-5 of the proposed NARC renewal, we intend to take identified compounds from other NARC Projects that can be thoroughly assessed using the relapse model. In summary, Project 4 will provide for the systematic examination of testable drug interventions derived from studies within the NARC. Other projects within the NARC, in particular Project 1, will identify future targets of intervention as anti-relapse medications. By applying a seamless model of testing in conjunction with the NARC Animal Core, we will establish a template for the testing of putative medications as they are derived from NARC projects to serve as a bridge to clinical testing of such agents through the NARC Pilot Core. The results from these integrated studies will hopefully lead to useful pharmacotherapeutic agents for the

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA015369-10
Application #
8377637
Study Section
Special Emphasis Panel (ZDA1-RXL-E)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
10
Fiscal Year
2012
Total Cost
$109,597
Indirect Cost
$36,534
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Hanlon, Colleen A; Dowdle, Logan T; Gibson, Nicole B et al. (2018) Cortical substrates of cue-reactivity in multiple substance dependent populations: transdiagnostic relevance of the medial prefrontal cortex. Transl Psychiatry 8:186
Roberts-Wolfe, Douglas; Bobadilla, Ana-Clara; Heinsbroek, Jasper A et al. (2018) Drug Refraining and Seeking Potentiate Synapses on Distinct Populations of Accumbens Medium Spiny Neurons. J Neurosci 38:7100-7107
Spencer, Sade; Neuhofer, Daniela; Chioma, Vivian C et al. (2018) A Model of ?9-Tetrahydrocannabinol Self-administration and Reinstatement That Alters Synaptic Plasticity in Nucleus Accumbens. Biol Psychiatry 84:601-610
Parrilla-Carrero, Jeffrey; Buchta, William C; Goswamee, Priyodarshan et al. (2018) Restoration of Kv7 Channel-Mediated Inhibition Reduces Cued-Reinstatement of Cocaine Seeking. J Neurosci 38:4212-4229
Kearney-Ramos, Tonisha E; Lench, Daniel H; Hoffman, Michaela et al. (2018) Gray and white matter integrity influence TMS signal propagation: a multimodal evaluation in cocaine-dependent individuals. Sci Rep 8:3253
Giannotti, Giuseppe; Barry, Sarah M; Siemsen, Ben M et al. (2018) Divergent Prelimbic Cortical Pathways Interact with BDNF to Regulate Cocaine-seeking. J Neurosci 38:8956-8966
Siemsen, Ben M; Lombroso, Paul J; McGinty, Jacqueline F (2018) Intra-prelimbic cortical inhibition of striatal-enriched tyrosine phosphatase suppresses cocaine seeking in rats. Addict Biol 23:219-229
Bobadilla, Ana-Clara; Heinsbroek, Jasper A; Gipson, Cassandra D et al. (2017) Corticostriatal plasticity, neuronal ensembles, and regulation of drug-seeking behavior. Prog Brain Res 235:93-112
Barry, Sarah M; McGinty, Jacqueline F (2017) Role of Src Family Kinases in BDNF-Mediated Suppression of Cocaine-Seeking and Prevention of Cocaine-Induced ERK, GluN2A, and GluN2B Dephosphorylation in the Prelimbic Cortex. Neuropsychopharmacology 42:1972-1980
Spencer, Sade; Kalivas, Peter W (2017) Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse. Int J Neuropsychopharmacol 20:797-812

Showing the most recent 10 out of 180 publications